（文章来源：证券日报） 证券日报网讯 1月16日，保利联合发布公告称，公司于2026年1月16日召开第七届董事会第二十一次会 议，审议通过《关于聘任公司董事会秘书的议案》，同意聘任公司副总经理张宝亮先生担任公司董事会 秘书。 ...

格隆汇1月16日丨保利联合（维权）(002037.SZ)公布，保利联合化工控股集团股份有限公司于2026年1 月16日召开第七届董事会第二十一次会议，审议通过《关于聘任公司董事会秘书的议案》，同意聘任公 司副总经理张宝亮先生担任公司董事会秘书。 ...

证券代码：002037 证券简称：保利联合 公告编号：2026-03 保利联合化工控股集团股份有限公司 关于聘任董事会秘书的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导 性陈述或重大遗漏。 保利联合化工控股集团股份有限公司（以下简称"公司"）于 2026 年 1 月 16 日召开第七届董事会第二十一次会议，审议通过《关于聘任 公司董事会秘书的议案》，同意聘任公司副总经理张宝亮先生担任公 司董事会秘书，现将有关情况公告如下： 一、董事会秘书聘任情况 根据《公司法》《公司章程》等相关规定，经公司董事长提名、 董事会提名委员会资格审查通过，董事会决定聘任公司副总经理张宝 亮先生担任公司董事会秘书（简历详见附件），任期自本次董事会审 议通过之日起至第七届董事会任期届满之日止。 电子邮箱：bllh@polyunion.cn 1 联系地址：贵州省贵阳市观山湖区石林东路 9 号 1 号楼 特此公告。 保利联合化工控股集团股份有限公司董事会 2026 年 1 月 16 日 2 张宝亮先生目前尚未取得董事会秘书资格证书，其已书面承诺将 参加最近一期董事会秘书资格培训并取得深圳证券交易所认可 ...

保利联合公告称，公司第七届董事会第二十一次会议于2026年1月16日以通讯表决方式召开。会议审议 通过《关于聘任公司董事会秘书的议案》，经董事长提名，同意聘任公司副总经理张宝亮担任公司董事 会秘书，任期自本次董事会审议通过之日起至第七届董事会任期届满之日止。表决结果为同意7票，反 对0票，弃权0票。 ...

审议通过《关于聘任公司董事会秘书的议案》。 第七届董事会第二十一次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导 性陈述或重大遗漏。 保利联合化工控股集团股份有限公司（以下简称"公司"）第七 届董事会第二十一次会议通知于 2026 年 1 月 13 日通过电子邮件发出， 会议于 2026 年 1 月 16 日以通讯表决方式召开。本次会议应参加表决 董事 7 名，实际参加表决董事 7 名。本次会议的召集和召开符合《中 华人民共和国公司法》和《公司章程》的规定。根据《深圳证券交易 所股票上市规则》的有关规定，现将会议审议情况公告如下： 一、议案审议情况 证券代码：002037 证券简称：保利联合 公告编号：2026-02 保利联合化工控股集团股份有限公司 经董事长提名，聘任公司副总经理张宝亮先生担任公司董事会秘 书，任期自本次董事会审议通过之日起至第七届董事会任期届满之日 止。 表决结果：同意 7 票，反对 0 票，弃权 0 票。 特此公告。 保利联合化工控股集团股份有限公司董事会 2026 年 1 月 16 日 2 1.公司第七届董事会第二十一次会议决议； 2.公司董 ...

Group 1 - The core issue involves Poly United's financial misconduct, which was revealed in early 2024, where the company inflated net profits through various means from 2019 to 2021 [1][2] - The primary method of deception included misclassifying ordinary accounts receivable as secured debts, thereby artificially lowering risk categorization [1][3] - Due to errors in aging classification and calculations, the company significantly underreported bad debt provisions, leading to inflated net profits over three consecutive years and a fundamental reversal of profit and loss in 2021 [1][3] Group 2 - The integrity of information disclosure is crucial for the capital market, and Poly United's actions represent a serious violation of market trust and investor decision-making rights [2][4] - Investors who purchased shares between April 28, 2020, and January 20, 2023, and sold or still hold shares after January 21, 2023, may be eligible for compensation, with a claim deadline of January 20, 2026 [2][4] - The urgency for affected investors to join the compensation process is emphasized, as legal protections do not extend to those who delay their claims [2][4]

2024年1月16日晚，保利联合公告收到证监会贵州监管局下发的《行政处罚决定书》，经查明，保利联 合存在以下违法事实： 2019年至2021年期间，新联爆破与浙商银行签订《应收账款链平台业务合作转让协议》，据此终止确认 应收账款；新联爆破与国新商业保理有限公司签订《国内无追索权保理业务合同》，并于同日签订附追 索权的《补充协议》，新联爆破据此终止确认应收账款；保利联合以与客户签订《资金支付协议》《还 款协议》及期后签订《资产抵押协议》等为由，将部分应收账款视为有担保的债权，错误划分风险组 合；保利联合因应收账款账龄划分及计算错误，导致公司少计提坏账准备。 以上行为致使2019年保利联合少计提坏账准备43，121，976.07元，虚增净利润36，653，679.66元，占 当期披露金额的19.95%；2020年少计提坏账准备77，752，927.99元，虚增净利润65，892，497.89元， 占当期披露金额的43.24%；2021年少计提坏账准备235，768，852.67元，虚增净利润200，267，416.27 元，占当期披露金额的124.47%，导致2021年盈亏发生变化。 专门从事股票索赔法律事务的上 ...

Investment & Operations - Aimeike's exclusive distribution of botulinum toxin type A injection product has received drug registration certificate [1] - Kangtai Biological's clinical trial application for acellular pertussis-diphtheria-tetanus (component) combined vaccine has been accepted [1] - Runjian Co. signed a strategic cooperation framework agreement with JD Technology to expand in AI applications and intelligent computing cloud [1] - Zhongwu Drone signed a contract for drone systems worth over 100 million, expected to positively impact annual operating performance [1] - Jiechuang Intelligent plans to procure IT equipment and spare parts totaling no more than 4 billion for cloud computing business [1] - Pairui Co. signed a bulk procurement framework agreement for IGBT chips, with forecasted supply total amounting to approximately 131.4 billion for 2028, 2029, and 2030 [1] - Poly United won a bid for a 1.528 billion yuan stripping engineering project [1] - Quanxin Co. plans to issue convertible bonds to raise no more than 312 million for commercial aviation transmission and integrated communication products [1] - Guangdong Power A's Huizhou power plant expansion project (2×1000MW) has commenced operation for unit 5, with a total investment of 8.05 billion [1] - Changhong Technology's subsidiary has secured semiconductor consumables orders from a major domestic wafer factory, expected to account for over half of procurement share by 2026 [1] Performance - Jinli Permanent Magnet expects a net profit increase of 127%-161% year-on-year for 2025, with small batch deliveries of embodied robot motor rotors and magnetic materials [1] - Yingqu Technology anticipates a net profit increase of 114.69%-162.40% year-on-year for 2025 [1] - Absen expects a net profit increase of 105.32%-148.09% year-on-year for 2025 [1] - Industrial Fulian plans to distribute cash dividends totaling 6.55 billion (including tax) for the first half of 2025, with the equity registration date set for January 15, 2026 [1] Capital Operations - Beifang Changlong plans to acquire 51% of Shunyi Technology, expected to constitute a major asset restructuring [2] - Huibo Pu is planning to transfer 25%-30% of its shares, leading to stock suspension [2] - Tiansheng New Materials' largest shareholder Wu Haizhou is planning significant matters that may lead to a change in control, resulting in stock suspension [2] - Quanyin High-Tech's offer from Zhongzhong Group has expired, and the stock will resume trading [2] - Kede Education's actual controller plans to transfer 23.57% of its shares, with Huaxin Future becoming the controlling shareholder [2]

（文章来源：证券日报） 证券日报网讯 1月8日，保利联合发布公告称，公司全资子公司保利特能工程有限公司下属控股子公司 内蒙古瀚石矿山工程有限公司（以下简称"内蒙古瀚石"）中标（能投公司）内蒙古大唐国际锡林浩特矿 业有限公司胜利东二号露天煤矿 2026-2030 年剥离工程二标段项目，中标报价 152，784.15 万元，计划 工期 2026 至 2030 年。近日，公司下属内蒙古瀚石与内蒙古大唐国际锡林浩特矿业有限公司签署了《内 蒙古大唐国际锡林浩特矿业有限公司胜利东二号露天煤矿 2026-2030 年土方石剥离工程（二标段）施工 合同》。 ...

Group 1 - Jinli Permanent Magnet expects a net profit of 660 million to 760 million yuan for 2025, representing a year-on-year growth of 127% to 161% [1] - Wens Foodstuffs anticipates a net profit of 5 billion to 5.5 billion yuan for 2025, a decrease of 40.73% to 46.12% compared to the previous year [2] - New Open Source plans to repurchase shares worth 40 million to 50 million yuan, with a maximum repurchase price of 25.77 yuan per share [3] Group 2 - Fosun Pharma's subsidiary has had a drug registration application accepted for a new drug targeting ALK-positive non-small cell lung cancer [4] - Leike Film reported a net profit of -86 million yuan for the first three quarters of 2025, indicating a potential annual loss [5] - Crown Stone Technology's application for a specific issuance of A-shares has been accepted by the Shanghai Stock Exchange [6] Group 3 - Dongxin Technology has completed the business registration change for its subsidiary, Lishuan Technology, and has invested 211 million yuan in it [7] - Tianci Materials has increased its commodity futures hedging business limit from 150 million to 300 million yuan [8] - Gaode Infrared's actual controller has reduced his shareholding by 0.54%, bringing his stake down to 62.95% [9] Group 4 - Tianyong Intelligent expects a net profit of 10 million to 15 million yuan for 2025, marking a turnaround from losses [10][11] - China Merchants Energy anticipates a net profit of 6 billion to 6.6 billion yuan for 2025, an increase of 17% to 29% year-on-year [18] - Guangdong Electric Power A's Huizhou Power Plant's Unit 5 has been put into commercial operation, with an investment of 8.05 billion yuan [19] Group 5 - Jianghuai Automobile reported a 42.24% year-on-year increase in sales volume for December 2025 [25] - China Pharmaceutical's subsidiary has received a drug registration certificate for a new medication [26] - TianNeng Co. plans to use up to 12 billion yuan of its own funds for entrusted wealth management [27] Group 6 - Luoyang Huizhong reported a 10.55% month-on-month decrease in sales revenue from live pigs for December 2025 [28] - Baolidi expects a net profit of 145 million to 152 million yuan for 2025, a year-on-year increase of 27.17% to 33.30% [30] - Changchun High-tech's subsidiary has had a melatonin granule registration application accepted [31] Group 7 - Zhongmin Energy reported a 4.46% year-on-year decrease in cumulative on-grid electricity for 2025 [32] - Huaxin Electronics reported a 7.79% year-on-year decrease in consolidated operating revenue for December 2025 [35] - Xiamen Airport reported a 2.79% year-on-year increase in passenger throughput for December 2025 [36] Group 8 - Baiyun Airport reported a 12.27% year-on-year increase in passenger throughput for December 2025 [37] - Pulaike has received a new veterinary drug registration certificate for a chewable tablet [38] - Yunnan Energy Holdings' subsidiary has reduced its stake to 84% after a capital increase [39] Group 9 - Gansu Energy Chemical's new thermal power project has successfully completed trial operation [41] - Zhenghong Technology reported a significant decrease in sales revenue from live pigs for December 2025 [42] - Huasheng Lithium Battery is planning to issue H-shares for listing on the Hong Kong Stock Exchange [43] Group 10 - Jincheng Mining has signed a mining production contract with an estimated total price of approximately 510 million yuan [44] - Microchip Biotech has received approval for clinical trials of a new drug for pancreatic cancer [45] - Yahon Pharmaceutical has completed the first patient enrollment for a Phase I clinical trial of its drug [46]